Pharmacy leaders have issued a new warning over the online sale of weight loss jabs (GLP-1s) and patient safety amid predictions of a boom in demand for the drugs this year.
Nuffield Health, the UK’s largest healthcare charity, is partnering with med tech giant GE HealthCare to deploy AI-powered diagnostic equipment across its hospital network.
The 20 year, £200 million deal will deliver nearly 800 AI devices with over 100 devices set for delivery in 2025, covering imaging, ultrasound, surgery, and x-ray.
Manipal Health Enterprises, one of India’s top five hospital groups, backed by Singapore's global investment company Temasek, is eyeing a $1 billion USD IPO, potentially valuing the company at $7.5 - 8 billion, according to LiveMint, a leading Indian business newspaper.
German property investor and developer Deutsche Wohnen has sold its nursing home subsidiary PFLEGEN & WOHNEN (P&W) to the Hamburg local authority for €380 million, effectively nationalising the group.
HBI spoke with Dr. Manuel Nothelfer, founder at Wellster Healthtech Group based in Germany, part of a digital ecosystem that integrates a range of medical brands including online medicinal weight loss service GoLighter. Ahead of him taking part in a panel session on prescription weight loss at the HBI conference in Paris in March, he gives us an insight into the GLP-1 market in Germany, Wellster’s GoLighter model (which includes nutritional advice), and business learnings from the Group, having achieved profitability in October.
This week’s infographic looks at the French laboratory testing volumes between 2019 to 2024.
The data is sourced from Assurance Maladie, France's national health insurance provider.
French private equity firm Ardian has raised a new secondaries platform with $30 billion of committed capital, making it the largest secondaries platform in history.
UK-based life sciences testing company Cormica, backed by the London-based private equity firm Limerston Capital, has acquired Zwisler Laboratorium, a German lab service provider. This marks Cormica’s entry into the German market and strengthens its prospects for European expansion.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.
